Rss Feed
Mesothelial cells enable rapid invasion and spread of ovarian cancer
Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen.
Burn pit particles trigger lung inflammation through immune activation
A new study from National Jewish Health helps explain how exposure to burn pit smoke and desert dust may damage the lungs of military service members deployed to regions such as Afghanistan and Iraq.
Children’s cooperative behaviors align with cultural norms over time
Children across the globe engage in a constellation of behaviors that support cooperation, an action critical to the survival of the human species, a team of Boston College researchers report today in the journal Science Advances.
High-dose motor therapy improves outcomes after perinatal stroke
In infants and toddlers who had a stroke before birth or as a newborn (28 days or younger), a treatment that combined restricting the use of the stronger arm with intensive task-oriented physical therapy led to improved function and skill gained on the weak side compared to standard care, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2026.
Moderate exercise lowers atrial fibrillation recurrence after ablation
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients a simple, low-cost way to support long-term heart health.
Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity
In recent years, cancer researchers have made major breakthroughs by using the body's immune system to fight cancer. One of the most promising approaches, known as immune checkpoint blockade, works by releasing molecular "brakes" on T cells.
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively.
American women show varied preferences for in-clinic versus at-home cervical cancer screening
American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools.
RNA micelles enable targeted chemotherapy without immune toxicity
A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or toxicity-related side effects.
Electroacupuncture relieves pain-induced anxiety through prefrontal neural circuits
Neuropathic pain, caused by injury or disease of the somatosensory nervous system, is a major clinical challenge and often evolves into a chronic condition.
Senescent neutrophils promote tumor survival across cancer types
Renowned as first responders to threatening infections, neutrophils also happen to feature prominently in the microenvironment of tumors, where they and other immune cells play opposing and frequently mutable roles in promoting-or resisting-cancer progression.
Dementia collaborative care delivers greater value than Alzheimer’s medication
Programs that match caregivers with patient navigators yield better outcomes than Alzheimer's drug – but combining the two may be best.
Griffith researchers on the cusp of new vaccine to prevent chikungunya
Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue.
Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.
Triple negative breast cancer cells use new strategy to boost metastatic ability
Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs.
Health harms from plastics could double by 2040
Global health burdens associated with plastic systems could double by 2040 without immediate and coordinated action.
Preoperative factors predict persistent opioid use after surgery
For many Americans, a routine surgical procedure serves as their first introduction to opioid pain medication.
Brain connectivity fingerprints differ in major depressive disorder
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve diagnosis and treatment.
Hormonal contraceptives show differing heart risks among stressed women
Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, "Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women."
Early biomarkers predict infections after breast reconstruction surgery
In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies.




